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ABSTRACT
Background: Informed consent is an important feature of longitudinal
research studies as it enables the linking of the baseline participant infor-
mation with administrative data. The lack of standardized models to cap-
ture consent elements can lead to substantial challenges. A structured
approach to capturing consent-related metadata can address these.
Objectives: a) Explore the state-of-the-art for recording consent; b) Identify
key elements of consent required for record linkage; and c) Create and
evaluate a novel metadata management model to capture consent-related
metadata. Methods: The main methodological components of our work
were: a) a systematic literature review and qualitative analysis of consent
forms; b) the development and evaluation of a novel metadata model.
Discussion: We qualitatively analyzed 61 manuscripts and 30 consent
forms. We extracted data elements related to obtaining consent for linkage.
We created a novel metadata management model for consent and evalu-
ated it by comparison with the existing standards and by iteratively apply-
ing it to case studies. Conclusion: The developed model can facilitate the
standardized recording of consent for linkage in longitudinal research
studies and enable the linkage of external participant data. Furthermore,
it can provide a structured way of recording consent-related metadata and
facilitate the harmonization and streamlining of processes.
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Introduction
Longitudinal health research studies provide a unique insight into the lives of people and are
fundamental to investigating disease etiology and prognosis. Researchers are increasingly linking
investigator-led studies, clinical cohorts, genomic datasets, and other administrative data sources
together to produce enriched datasets that accurately reflect the longitudinal nature of diseases and
capture the patient pathway through disease states.
There are two types of record linkage: a) deterministic record linkage which involves integrating
records using common unique identifiers (e.g. unique healthcare or social security identifiers) found
in multiple disparate datasets and b) probabilistic record linkage where the probability that two
disparate records relate to one individual is calculated. Informed consent is a key aspect of the health
research process and to enabling record sharing and linkage. When obtaining consent, individuals
can consent for themselves or on behalf of another; for example, a legal guardian/parent consenting
on behalf of an infant. In such scenarios, the extent to which a legal guardian/parent consents on
behalf of a child lessens as the child matures and their autonomy increases.1
When collecting research data as part of research studies, researchers handle consent in different
ways as no common standard approach exists. When linking data for participants located across
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different data sources, these different consent models and approaches must be harmonized and
aligned before data custodians and relevant governance bodies provide approval. By simplifying and
standardizing the consent process, there is the potential for researchers to better understand the
extent to which consent could have been given by participants and under which conditions.3 While
limited guidance on the format and wording of consent is available, information quickly becomes
out of date given the dynamic nature of the underlying ethical and legal frameworks and there is a
lack of standardized methods to record the process and capture accurate data.2,4,5 These incon-
sistencies between consent models often cause substantial delays in the data linkage process due to
delays in obtaining approval or may completely halt the process if no consensus is reached making
the standardization of the process crucial.
The aim of our work was to create and evaluate a novel metadata management model to enable
the capture of consent metadata associated with record linkage in longitudinal health studies in a
systematic and standardized manner. Specifically, we sought to: a) systematically identify and review
the current methodologies for recording consent; b) comprehensively review key consent elements of
contemporary longitudinal health research studies; and c) design, implement, and evaluate a novel
metadata model for capturing consent for record linkage.
Recording consent metadata in a structured and consistent manner can enable the develop-
ment of tools and methods to facilitate the automated or semi-automated generation and sharing
of consent metadata amongst stakeholders such as researchers, ethics committees, and data
custodians. Consequently, this can pave the way toward streamlining the process across the
scientific community and reducing the barriers which cause delays. The focus of our research
has not been to determine the best practice from the viewpoint of ethical bodies or data
custodians due to the dynamic nature and temporal changes in the underlying legal and ethical
frameworks, but to provide a structured manner in which stakeholders can capture, document,
and track the consent process. While the focus of this manuscript has been on longitudinal health
research studies, many of the challenges associated with the consent process apply to clinical
studies performed in healthcare settings and the proposed methodology can be adapted to apply
in that context.
Methods
Literature review
We performed a cross-disciplinary literature review in January 2016 to determine the current state-
of-the-art and identify literature describing the development of metadata management models to
capture consent for record linkage. We used PubMed, Ovid, Scopus, The Cochrane Library, JSTOR,
ACM Digital Library, Lecture Notes in Computer Science, Web of Science, Inspec, Google, Google
Scholar, Intute, and forward citation tracking6 to the source literature. The search terms used were:
‘consent forms’, ‘longitudinal studies’, ‘record linkage’, ‘informed consent’, and ‘consent models’. To
be included in the review, the results had to be available in English and either be openly accessible or
Table 1. Thematic analysis of manuscripts.
Theme Number of manuscripts
Analysis21–32 12
Comparison of models33–47 15
Consent aspects of secondary uses of data48,49 2
Development of a new model of consent/form50–54 5
Development of tools to assist consent process55,56 2
Discussion of a single model57–60 4
Establishing and/or improving participant understanding4,61–68 9
Other69–80 12
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accessible using institutional credentials. We synthesized the results by identifying the primary
theme of the manuscript and categorized results accordingly.
Metadata model implementation
In order to inform the design and development of our model, we comprehensively analyzed the
questions and accompanying text of 30 consent forms from nine longitudinal research studies
identified through a combination of desk research and engaging with stakeholders. Included studies
are investigator-led, longitudinal consented research studies with a substantial record linkage
component: ALSPAC7, Born in Bradford8, British Household Panel Survey9 (BHPS), Health
Survey for England10, Life Study11, Millennium Cohort Study12 (MCS), Scottish Health Surveys13,
UK Biobank14 and Understanding Society.15 We qualitatively analyzed the consent forms and
identified relevant consent elements that directly informed the creation of the model’s metadata
elements. The elements were subsequently grouped according to themes which were collated
inductively and iteratively. By adopting an object oriented modeling approach we constructed the
final metadata model.
Metadata model evaluation
We evaluated the developed model by iteratively applying/adjusting it to consent forms from case
studies (selected with the same criteria as before) in order to quantify its fit for purpose and critically
appraise it. The studies used in the evaluation phase were: the English Longitudinal Study of Ageing
(ELSA)16, the Canadian Longitudinal Study of Aging (CLSA)17 study, and Growing Up In Australia:
The Longitudinal Study of Australian Children (LSAC).18
Critical appraisal of DDI 3.2
We additionally mapped the identified metadata elements from our model to Data Documentation
Initiative 3.2 (DDI 3.2) elements in order to critically appraise its fitness for recording consent
elements in health research studies. The DDI is an XML-based metadata standard and was designed
and developed primarily to describe social sciences research data. The standard is schema-based and
currently there are two versions both incorporating Dublin Core elements: DDI-Codebook (DDI-2)
and DDI-Lifecycle (DDI-3). DDI-3 encourages a more real-time approach to marking up metadata
for long-term studies and provides mechanisms for metadata comparison. This was to determine the
extent to which consent for record linkage in longitudinal studies may be recorded using the
prevailing existing metadata standard. During our appraisal, we identified potential required exten-
sion which will be discussed.
Results
Literature review
We identified and reviewed 61 manuscripts (Figure 1) and categorized them into themes inductively
(Table 1) and iteratively: a) analysis – to either improve or establish knowledge; b) comparison of
models – comparison of different types of consent; c) consent aspects of secondary uses of data –
discussion of consent in the research context; d) development of tools to assist consent process –
development of methods to assist with management; e) discussion of a single model – discussion of a
single method of requesting consent; f) establishing and/or improving participant understanding –
development and/or discussion of methods/tools to improve patients’ and participants’ understand-
ing; and g) development of a new model/form and h) other – anything that does not fall under any
other category.
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Metadata model implementation
Through qualitative analyses of consent forms and their associated patient information leaflets
(where applicable) from the current longitudinal health research studies and stakeholder engage-
ment, we identified and extracted the entities involved in the consent process. These formed the
basic components of our metadata model for capturing consent in longitudinal studies: a) people, b)
consent form, c) personal records, and d) informational material. We provide additional information
on each component below.
People
We identified and extracted the common demographic details requested such as full name, dates and
signatures of those consenting, statement of whether consent was on behalf of a child, confirmation
of understanding statement and details of how to withdraw consent. The people most commonly
involved in the consent process were identified as the person consenting (interviewee), and in certain
situations, the person for whom consent is given if this is different from the interviewee. Others
include the interviewer or staff member, as referred to in UK Biobank, teacher in the MCS, and
General Practitioner (GP) in Life Study.
Consent form
We analyzed the composition and flow of information of the consent forms and identified a similar
basic pattern used across all forms: demographic details, questions/statements of consent and then
confirmation through the signing, dating, and printing of name on the form.
Personal records
Unsurprisingly, we identified that the most common type of record subjects were asked to consent
for linkage was health and the least frequently used was for obtaining a participant’s criminal
Records identified through 
database searching
(n = 769)
Additional records identified 
through other sources
(n = 52)
Records after duplicates removed
(n = 704)
Records screened
(n =  704)
Records excluded
(n = 68)
Full-text articles assessed 
for eligibility
(n = 636)
Full-text articles excluded 
as not relevant 
(n = 575)
Studies included in 
qualitative synthesis
(n = 61)
Figure 1. Literature review PRISMA flow diagram.
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records. We also identified that in the consent forms for the Born in Bradford and Life Study,
consent was requested to allow future contact with the participants. The longevity of such studies
must be matched with consent models reflective of this and so being able to record this kind of
information was critical to the development of our model.
Informational material
The final component focuses on the additional informational material such as leaflets which
accompanied consent forms. Informational material is often used to describe the consent process,
the flow of data and any regulatory or ethical considerations that are associated with participating
with a study. In all studies, the material also contains information on how to withdraw consent from
the study. Rarely, such as in the case of the ALSPAC study, the accompanying information describes
how data linkage works and provides case studies of where record linkage has been used in the past
and the benefits obtained from it.
Metadata model evaluation
We evaluated the model by iteratively applying it to the three test cases randomly selected from the
original pool of identified research studies (ELSA, CLSA, and LSAC) and documenting adjustments
made to encapsulate all information from each study.
Person
We applied the model to the first test case, ELSA, and found that the model provided the metadata
elements needed to record information about the interviewee and the interviewer. However, the
model lacked elements to record when the consent form was completed; this indicated that the
model needed revising to enable recording of this information. In terms of recording confirmation of
understanding, we were able to use the ‘Confirmation of understanding’ attribute as part of the
‘Person’ element. This is a key aspect of our model as the need for a standardized approach to
recording this kind of information is needed and this section of the model addresses this current
unmet need. We then applied the model to the second test case, CLSA. We found that the metadata
relating to the people involved could be recorded using the ‘Person’ element and the child elements,
‘Non-professional’ and ‘Professional’. In having two separate child elements, we were able to reduce
the number of repeating attributes in the model through the use of inheritance whilst enabling
ourselves to distinguish between the different types of people involved in the consenting process –
‘professional’ e.g. principal investigator and ‘non-professional’ e.g. interviewee. Following application
of the model to the second test case, we decided to create a new element, ‘date of completion’, and
that this should be moved, and joined to, the ‘consent form’ element. In doing so, we were able to
group together all the elements relating to the consent form itself to help users better navigate
through the model. The final test case used to evaluate the model was the LSAC study. Having
iteratively applied the model to the previous test cases and made changes, we were able to record
information such as ‘confirmation of understanding’ successfully.
Consent form
We firstly applied the model to ELSA to test how well our model could record information relating
to the consent form’s composition. We found that use of elements such as ‘Academic institution’
enabled us to record detailed information, particularly since this element inherits the ‘Ethics
approval reference’ and ‘Organization name’ attributes from the ‘Organization’ element. In using
object-oriented modeling techniques, we were able to harness the advantages of a typically computer
science technique for life sciences research. Following this initial test, we identified areas for
improvement. For example, the ELSA consent form contains a set of instructions detailing what
to do with the completed form – one copy is retained by the participant and the other is returned to
the office. The model does not contain an element to record this information and so an additional
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element was needed. We altered our model accordingly, by adding ‘Instructions for next steps’, and
applied the revised version to the second test case. The results of the second test, using the CLSA
consent form, showed us that by adding the new element, we were then able to record more detailed
information about this aspect of the consent process. The results of the second test also demon-
strated that by harnessing the element such as ‘Questions’, as composed of ‘Logic’, ‘Responses’,
‘Purpose’, forming a part of the ‘Data collection’, we were able to record the questions and question
logic of the consent form in detail. This is important as being able to identify and record the
minutiae around this aspect of the consent process can potentially give stakeholders greater support
in determining the scope of consent. The model was then reapplied to the final test case, LSAC.
Here, we were able to test how well the model could, for example, record introductory information.
Recording this information involved use of the ‘Aim’ and ‘Undertakings’ elements which are a part
of the ‘General’ elements.
Personal records
Our model contains six different types of record: ‘Economic’, ‘Education’, ‘Legal’, ‘Family’, ‘Mobile
phone usage’, and ‘Health’. We applied the model to the first test case, ELSA, and found we were
able to record previous hospital visits and treatments through the ‘Health’ element and one of its
child elements, ‘Past’. In having a child element ‘Past’, in addition to two others, ‘Present’ and
‘Future’ we were able distinguish between these different events. In terms of recording economic
information for example, we used the ‘Economic’ elements with attributes: ‘Benefits claims’, ‘NI
contributions’, and ‘Tax’. However, to enhance the model further, we decided to convert these
attributes into separate elements which, when combined, create the ‘Economic’ element. We made
this change to simplify the recording of this kind of information; in terms of cardinality, there would
be no restrictions on the number of times elements can be used. We then applied the model to the
second test case and were able to record health related information using the existing ‘Health’
element’. For the third test case, the LSAC study, we again used the ‘Health’ element but also used
the ‘Persons’ element in addition to sufficiently record this information.
Information document
The results of the application to the ELSA study consent form demonstrated that to record different
kinds of informational documents, the parent element, ‘Participant Information document’ and the
child element ‘General’ needed to be combined to form a new element, ‘Informational document’
with ‘accessibility’, ‘audience’, and ‘type’ as attributes. This enabled the recording of, and differentia-
tion between, the different types of informational document. However, we were not able to locate
additional informational material online for ELSA; we also experienced this problem for the CLSA
study. Therefore, we decided to proceed to the third test case, LSAC, to continue testing this aspect
of the model. During the final test, we were able to use the newly-created ‘Informational document’
to specify the document type – in this case it was the corresponding information sheet. In making
this change to the model, we reduced the total number of elements whilst increasing scope to record
metadata relating to the different kinds of informational document. This is an advantage of using a
formalized modeling technique as changes were made quickly without impacting the rest of the
model. We then recorded the description of the study using the ‘Study’ element with attributes,
‘Aims’, ‘Contact details’, ‘Funding bodies’, ‘Objectives’, and ‘Reviewers’.
Critical appraisal of DDI 3.2
We critically evaluated the DDI 3.2 metadata standard by assessing its feasibility to map and record
each consent element from the basic components of our metadata model.
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People
Half of the consent metadata elements were directly mapped to DDI elements. General metadata
elements such as full name, location, nationality, contact details and date of consent can be mapped
directly using the ‘FullName’, ‘LocationName’, ‘Country’, ‘TelephoneNumber’, ‘Email’, and ‘Date’
elements, respectively, allowing for the relatively accurate reflection of the people involved in the
consenting processes. However, a fundamental aspect of consenting process associated with long-
itudinal studies is the possibility for the interviewee to consent on behalf of another person; for
example, a mother consenting on behalf of her infant or a legal guardian consenting on behalf of
somebody who is unable to provide consent on their own. We were unable to accurately capture and
reflect this in DDI. Stakeholders could potentially use the ‘Note’ element along with another element
to record this information. While this approach works in the short term, as the infant matures, and
they become more able to assent/dissent, DDI lacks the necessary mechanisms to record this level of
interaction in detail. Additional elements are needed in DDI to enable the recording of these critical
pieces of metadata.
Consent form
We were able to map almost all of consent metadata elements to DDI elements. This process was
fairly straightforward and we found that the majority of elements could be mapped directly. This is
due to the fact that consent forms are a type of survey instrument and this is exactly what DDI is
designed to capture. In some cases, such as responses, we identified two DDI elements which could
be potentially used to record metadata – text can be recorded using ‘ResponseText’; or stakeholders
could select a response from a predetermined, named list and use a combination of, ‘CodeList’,
‘CodeListName’, and ‘CodeListReference’ DDI elements. Nevertheless, DDI again lacks the elements
needed to record the minutia. For example, we found that ‘Undertakings’ and ‘Confirmatory
information’ could not be mapped directly to a DDI element. Again, while a potential work-around
solution would be to use the ‘Note’ element to hold the necessary information and then attach this to
another maintainable object, this is not a scalable approach and new DDI elements are required to
accurately capture all the consent form elements required.
Personal records
All metadata elements related to personal records were mapped to DDI elements. For example, we
were able to group together organizations and assign a group name. Here, the element
‘CodeListGroup’ can be used to specify the name of the group; while ‘CodeList’ will enable
stakeholders to record the possible clinical terminologies used such as the International
Classification of Diseases or SNOMED-CT. DDI 3.2 has built-in mechanisms to successfully record
code lists and categories so the process of providing links between these elements was relatively
straightforward. Other areas in which the DDI provided the necessary mechanisms to map directly
included location – ‘LocationName’. However, the results of this analysis demonstrated that a direct
link from elements associated with, ‘Treatments and management of conditions’ and ‘Tests and
assessments’ to elements in DDI was not possible. Having access to this kind of metadata in a
standardized and simplified format is key to supporting stakeholders in determining, use of health
services (part of the current treatment and management of conditions) and rights to results (part of
tests and assessments).
Informational material
We were able to map roughly half of consent metadata elements to DDI elements which can
successfully record information about the study and study objectives using the ‘Citation’ element.
Other elements such as funding bodies can also be mapped directly using the,
‘FundingInformation’ element. Another advantage of using DDI is that lifecycle events, such as
a participant withdrawing their consent can be recorded, and mapped relatively easily. Here, a
combination of ‘EventType’ and ‘LifecycleEvent’ would enable stakeholders to record this
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information in a clear and standardized manner. This is very important as the boundaries of
consent have a direct impact on researchers wanting to use certain research data. DDI also
enables stakeholders to create multiple lifecycle events. This can be used to the stakeholders’
advantage as they can record any additional relevant events in a systematic and robust manner.
However, stakeholders are again restricted in recording details specific to consent for record
linkage. For example, there are no elements in DDI which can be mapped directly enabling the
recording of, use of biological samples and how these will be acquired. Being able to record, and
have access to, this kind of metadata is important to informing potential secondary users of
which biological samples could be used as part of their further analyses of the research data.
Furthermore, having access to this kind of metadata can also help other stakeholders, such as
potential participants understand what could be requested of them should they partake in the
study.
Discussion
During the initial literature review and following the thematic analysis of identified manuscripts, we
were unable to identify any previous research focusing on the development of a metadata manage-
ment model to record consent for record linkage in longitudinal health research studies. The search
terms we used were specific to public health and epidemiological research and not readily used in
other domains such as computer science. Therefore, possible differences in use of controlled
vocabularies and terminologies may have negatively impacted our searching for literature.
Additionally, as a result, our review did not include a body of methodological research on consent
as it tends to focus on individual factors influencing the willingness of survey respondents such as,
for example, the placement of wording on a consent form and was deemed to be outside the context
of our study. Nevertheless, the literature review suggested that research into the development of
consent models to record informed consent for record linkage in longitudinal studies is limited and
merits further research.
The use of an object oriented approach to the design of our model, particularly inheritance and
aggregation enabled us to reduce data repetition and reduce the overall model complexity and size.
By using inheritance, multiple elements could share attributes. For example, in the consent form
section using the third test case, in having a generalized parent element of ‘Organization’, attributes
such as ‘Organization name’ are inherited by every child element helping to produce a simplified
model capable of recording low level detail. The use of aggregation enabled us to specify the
elements needed to compose metadata relating to the questions (using the ‘Questions’ element), or
in this case, the three statements. This is an advantage of using object oriented modeling techniques
to design and develop the model. As part of section D, an example is provided describing potential
information that may be accessed. This may be captured using the ‘Research’ element as part of the
‘Informational document’ element.
Given the increasing costs of primary data collections associated with longitudinal health studies,
a recent direction is to deploy a mixed-mode design i.e. involving a combination of offline paper-
based and online form-based data collection instruments. In the UK for example, the National Child
Development Study (NCDS) Age 55 Survey adopted a sequential mixed-mode design whereby study
members were first invited to participate online, with non-respondents being followed up by
telephone.19 The developed metadata model enables researchers and other stakeholders to record
the manner in which consent is provided using the ‘Method of collection’ element (which is a part of
the ‘Data collection’ element through aggregation). This provides users with the flexibility to
distinguish between modes of consent (e.g. self-completion, interview-driven) given that methodo-
logical research in the area illustrates how self-completion has lower response rates than interviewer
based models and can potentially introduce sample bias.20
A potential weakness of our approach and model lies in the fact that currently identifying
metadata elements involves a qualitative analysis of the current consent forms and there is the
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potential for bias given the potential subjectivity of the process. Ideally, the entire process would be
automated and identification of concepts would be through use of a predefined concept list, possibly
structured using a pre-defined ontology, from which concepts may be selected and assigned. In
having a fully automated process, this could potentially reduce human error and scope for bias.
Furthermore, information documents could not be found online for ELSA and CLSA studies. This is
a weakness in our approach to evaluating the model as this section of the model was not tested to the
same extent as the other three sections. To enhance the model further, the ‘type of test’ and ‘storage
of sample’ attributes of the ‘health’ element could be removed and placed in a new element entitled
‘biological samples’. Having a separate element for this information widens the scope for further
extension and enables additional, element-specific attributes to be added such as name and site of
labs. This could also potentially improve the extent to which dynamic consent may be captured as
changes in the model would facilitate the recording of more low level detail e.g. the title of the
particular test (such as the blood test) for which dynamic consent may be given – enabling consent
to be given for the use of some tests and not others. Our model and approach focused on low-level
metadata elements rather than wording or placement of elements on the consent form the focus of
our research was not to determine what works best or how to maximize consent rates (as outlined
above) but rather to provide an underlying structure and a mechanism to systematically capture and
characterize that structure.
Finally, the results of the critical analysis indicated that whilst many DDI 3.2 elements may be
harnessed to create standardized descriptions of consent for record linkage in longitudinal studies,
the standard lacks the mechanisms needed to record low level metadata specific to epidemiological
and public health research. It is in these areas in particular that the standard fails to provide the
necessary mechanisms to record consent for record linkage using metadata elements effectively. For
example, it was challenging to identify and select which elements could be used individually or
together to record the interviewee’s thought process and reasoning when deciding the extent to
which they would like to consent. It is having access to these details which could potentially better
support researchers in undertaking analyses using record linkage. This is because these explanations
could potentially provide the context with greater detail which researchers could potentially find
useful. The advantage of DDI 3.2 sits very much in the opportunity for stakeholders to package
together standardized instances of metadata in an interoperable format (XML) which can then be
published as a ‘StudyUnit’. These instances may be entered into inter/national catalogues where they
can be actively maintained. Subsequently, stakeholders such as potential secondary users, members
of the public, and in addition to others, may view these metadata records to better inform themselves
of the past and current longitudinal studies. Consequently, stakeholders can potentially have a
greater understanding of what could be achieved if access to the data and/or biological samples
was granted.
Conclusion
Longitudinal health research studies are critical to investigating disease aetiology and prognosis
and its impact across the life course. There is a distinct lack of standardized approaches to
recording the metadata associated with consent to record linkage for such studies despite the fact
that they are considered crucial and are widely used. In this study, we created and evaluated a
novel metadata model to record consent for record linkage using metadata elements. The novel
metadata management model can now assist researchers and other stakeholders in recording
standardized descriptions of the consent process and facilitate the harmonization of the process
across multiple research studies. Our long-term goal is to integrate the metadata model into a
software tool which can assist stakeholders in recording consent for record linkage metadata
using semi-automated processes and allow the sharing of computable consent-form definitions
across the wider scientific community.
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Key messages
(1) While obtaining informed consent from patients and participants is an important aspect of
health research studies, as outlined by a systematic literature review, no common standar-
dized approach for capturing and recording consent elements for health research currently
exists.
(2) A qualitative review of 30 consent forms from the existing longitudinal health research
studies illustrated significant variation in terms of the type and manner of the information
collected during the consent process.
(3) The lack of systematic and standardized approaches to recording consent leads to significant
delays in undertaking longitudinal health research studies, limits their secondary use by
other researchers, and makes the linkage of multiple datasets challenging.
(4) Standardized metadata models for capturing and recording consent across research studies
can address some of these challenges and enable scientists to link disparate health datasets
for research. Additionally, they can pave the way for streamlining the consent process and
developing software applications to automate the process.
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